AusCann Group Holdings Ltd (ASX: AC8) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.Auscann Group Holdings Ltd (ASX: AC8) Latest News
CBD to be sold in pharmacies, ASX cannabis shares react
Kate O'Brien | February 8, 2021 9:21am
Why the AusCann (ASX:AC8) share price jumped 14% higher today
James Mickleboro | January 8, 2021 10:14am
Elixinol (ASX:EXL) share price tumbles on capital raising update
Brendon Lau | December 4, 2020 2:54pm
ASX stock of the day: CannPal Animal Therapeutics (ASX:CP1) shares shoot 25%
Sebastian Bowen | November 17, 2020 12:54pm
Look out for the Auscann (ASX:AC8) and Cannpal (ASX:CP1) share prices post trading halt
Bernd Struben | November 16, 2020 4:59pm
Auscann (ASX:AC8) share price climbs higher on sale agreement
Aaron Teboneras | November 10, 2020 3:43pm
Recent Stock Announcements
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About AusCann Group Holdings Ltd (ASX: AC8)
Auscann Group Holdings Ltd (ASX: AC8) is a pharmaceutical company based in Western Australia. Its focus is on developing, producing and distributing a range of cannabinoid treatments for use in Australia and internationally.
According to Auscann, the company’s products are the result of a stringent development program that aims to produce stable and effective cannabinoid-based medicines. Auscann also seeks to generate clinical evidence supporting the efficacy of its products to support further market penetration.
Whilst working directly with patients, Auscann’s primary focus is on providing healthcare professionals with optimal treatment solutions to help them better care for their patients. The company also provides healthcare professionals with the tools to personalise and adjust dosage and treatment programs for each individual.
AusCann was readmitted to the ASX in early 2017 after it was acquired by the already listed company TW Holdings Limited. In the months following, the Auscann share price surged by nearly 200%. Within 12 months, the Auscann share price had gone on to deliver growth of nearly 500% over its ASX readmittance value. Since then however, the Auscann share price has trended lower and has not traded over $1 since late 2018.
Share Price History
Data provided by Morningstar.| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 01 Mar 2021 | $0.15 | $-0.01 | -6.25% | 1,377,409 | $0.17 | $0.17 | $0.15 |
| 26 Feb 2021 | $0.16 | $-0.01 | -6.06% | 1,589,390 | $0.16 | $0.17 | $0.16 |
| 25 Feb 2021 | $0.17 | $-0.01 | -5.88% | 2,800,021 | $0.18 | $0.18 | $0.17 |
| 24 Feb 2021 | $0.17 | $0.00 | 0.00% | 839,226 | $0.18 | $0.18 | $0.17 |
| 23 Feb 2021 | $0.18 | $-0.01 | -5.56% | 776,243 | $0.18 | $0.18 | $0.17 |
| 22 Feb 2021 | $0.18 | $0.01 | 5.88% | 1,061,165 | $0.17 | $0.18 | $0.17 |
| 19 Feb 2021 | $0.17 | $0.00 | 0.00% | 1,663,547 | $0.18 | $0.18 | $0.17 |
| 18 Feb 2021 | $0.18 | $-0.01 | -5.56% | 782,609 | $0.18 | $0.18 | $0.18 |
| 17 Feb 2021 | $0.18 | $-0.01 | -5.41% | 1,252,769 | $0.19 | $0.19 | $0.18 |
| 16 Feb 2021 | $0.19 | $0.01 | 5.56% | 1,186,488 | $0.19 | $0.19 | $0.18 |
| 15 Feb 2021 | $0.18 | $0.01 | 5.71% | 1,758,845 | $0.19 | $0.19 | $0.18 |
| 12 Feb 2021 | $0.18 | $-0.01 | -5.41% | 3,128,503 | $0.18 | $0.19 | $0.18 |
| 11 Feb 2021 | $0.19 | $-0.02 | -10.00% | 9,958,606 | $0.21 | $0.21 | $0.19 |
| 10 Feb 2021 | $0.20 | $0.02 | 11.11% | 16,588,450 | $0.19 | $0.21 | $0.18 |
| 09 Feb 2021 | $0.18 | $0.01 | 5.71% | 2,500,025 | $0.18 | $0.19 | $0.18 |
| 08 Feb 2021 | $0.18 | $-0.01 | -5.56% | 514,122 | $0.18 | $0.18 | $0.18 |
| 05 Feb 2021 | $0.18 | $-0.01 | -5.41% | 1,305,029 | $0.19 | $0.19 | $0.18 |
| 04 Feb 2021 | $0.19 | $0.01 | 5.56% | 1,884,418 | $0.19 | $0.20 | $0.19 |
| 03 Feb 2021 | $0.18 | $0.01 | 5.71% | 803,700 | $0.18 | $0.19 | $0.18 |
| 02 Feb 2021 | $0.18 | $-0.01 | -5.56% | 905,967 | $0.18 | $0.19 | $0.18 |
| 01 Feb 2021 | $0.18 | $0.01 | 5.88% | 1,312,146 | $0.18 | $0.19 | $0.17 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| The Trust Company (Australia) Limited <M0F> A/C | 39,000,000 | 12.30% |
| Citicorp Nominees Pty Limited | 11,714,708 | 3.38% |
| Ms Elaine Lucy Darby | 6,816,838 | 2.15% |
| Merrill Lynch (Austraua) Nominees Pty Umited | 5,875,409 | 1.85% |
| Mal Washer Nominees Ft( Ltd | 5,300,632 | 1.67% |
| J P Morgan Nominees Austraua Limited | 4,463,186 | 1.41% |
| Mr Warren Sidney Langman | 4,235,928 | 1.34% |
| HSBC Custody Nominees (Australia) Limited | 2,999,292 | 0.95% |
| BNP Paribas Nominees Pty Ltd < Ib Au Noms Retail Went Drp> | 2,805,532 | 0.88% |
| Celtic Capital Pty Ltd <Celtic Capital A/C> | 2,348,106 | 0.73% |
| Wil & Jack Ft( Ltd <Wil & Jack Family A/C> | 2,348,106 | 0.74% |
| Mr George Chien Hsun Lu & Mrs Jenny Chin Pao Lu | 2,195,000 | 0.69% |
| Danny Stephens Investments Pty Ltd <Danny Stephens Family A/C> | 2,150,200 | 0.68% |
| Mr Anthony Nicholas Nagy | 2,061,846 | 0.65% |
| Bnp Paribas Noms Pty Ltd < Drp> | 1,941,237 | 0.61% |
| Pershing Australia Nominees Pty Ltd <Accum A/C> | 1,726,435 | 0.54% |
| Noldex Pty Ltd | 1,573,918 | 0.50% |
| Mr George Chien Hsun Lu | 1,390,000 | 0.44% |
| HSBC Custody Nominees (Australia) Limited (I) | 1,257,407 | 0.40% |
| Alava Holdings Limited | 1,250,000 | 0.39% |